StocksHealthcareCTKB

CTKB

CYTEK BIOSCIENCES, INC.
NasdaqResearch view
Healthcare · Laboratory Analytical Instruments · Small-cap · SEC EDGAR FY 2025-12-31

Price history

🔒 Click to interact · scroll moves the page

Snapshot

SEC EDGAR · FY 2025-12-31
SectorHealthcare
Market Cap$688.9M
Enterprise Value$598.1M
Income$-66.5M
Sales$201.5M
Book/sh$2.63
Cash/sh$0.70
Dividend TTM
Payout
Employees
IPO
Quick Ratio4.42
Current Ratio5.04
Debt/Eq
EPS (ttm)$-0.09
EPS this Y-550.0%
EPS past 3/5Y
Sales past 3/5Y7.1%
EPS Y/Y TTM-550.0%
Sales Y/Y TTM0.5%
Shs Outstand129.98M
ROA-14.4%
ROE-19.5%
ROIC-35.9%
Gross Margin51.8%
Oper. Margin-20.0%
Profit Margin-33.0%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.
Revenue & Earnings — fiscal year
$128.0M
2021
$164.0M
2022
$193.0M
2023
$200.5M
2024
$201.5M
2025

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it
USDFY2021FY2022FY2023FY2024FY2025

Deep dive

Computed from the SEC EDGAR multi-year statements

Operating leverage — margins

GrossOperatingNet
0%40%80%52%-20%-33%FY21FY22FY23FY24FY25

FY25 cash-flow waterfall

Cash-flow detail unavailable in this filing.
COMMUNITY · $CTKB0 theses
POST YOUR TAKE →

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.